Market Place
Sourcing Support
ReNeuron joins exodus from AIM exchange after missing fundraising goal
30 Aug 2024 //
FIERCE BIOTECH
ReNeuron lays off 40% of staff to buy time for exosome pivot
19 Jan 2023 //
FIERCE BIOTECH
ReNeuron: Catherine Isted appointed as CEO
01 Aug 2022 //
RTTNEWS
Director Change
11 Feb 2022 //
RENEURON
First subject treated at Oxford Eye Hospital in Phase 2a RP trial
18 Oct 2021 //
RENEURON
ReNeuron Announces Further Positive Data in Retinal Clinical Trial
29 Jun 2020 //
PRNEWSWIRE
ReNeuron Announces CTX Cell Line Shows Further Potential
07 May 2020 //
PRNEWSWIRE
ReNeuron Announces Exosome Research Collaboration
07 Apr 2020 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.